Table 2.
†. Demographic, tumor and hospital characteristics by treatment and stage, (weighted row %).
| All Stages, (n=787) | T4 Stage Only, (n=182) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| Characteristics | Surgery (n=284) |
RTC (n=503) |
Row total, n | P value‖ | Surgery (n=42) |
RTC (n=140) |
Row total, n | P value‖ | |
| Year | 1997 | 59% | 41% | 115 | 43% | 57% | 31 | ||
| 2004 | 38% | 62% | 359 | 18% | 82% | 75 | |||
| 2009 | 28% | 72% | 313 | 0.0006* | 15% | 85% | 76 | 0.0442* | |
|
| |||||||||
| Age | 20–49 | 44% | 56% | 162 | 20% | 80% | 39 | ||
| 50–64 | 35% | 65% | 421 | 17% | 83% | 98 | |||
| 65+ | 34% | 66% | 204 | 0.40 | 28% | 72% | 45 | 0.51 | |
|
| |||||||||
| Sex | Female | 45% | 55% | 249 | 23% | 67% | 61 | ||
| Male | 35% | 65% | 538 | 0.08 | 20% | 80% | 121 | 0.76 | |
|
| |||||||||
| Race | Non-white | 31% | 69% | 339 | 21% | 79% | 100 | ||
| White | 37% | 63% | 448 | 0.13 | 21% | 79% | 82 | 0.97 | |
|
| |||||||||
| Marital status | Married | 39% | 61% | 385 | 28% | 72% | 72 | ||
| Unmarried | 33% | 67% | 402 | 0.40 | 17% | 83% | 110 | 0.23 | |
|
| |||||||||
| Health | Yes | 36% | 63% | 718 | 20% | 80% | 162 | ||
| Insurance | No/Unknown | 37% | 63% | 69 | 0.93 | 29% | 61% | 20 | 0.47 |
|
| |||||||||
| Charlson | 0 | 38% | 62% | 581 | 22% | 78% | 135 | ||
| Score | ≥ 1 | 32% | 68% | 206 | 0.42 | 18% | 82% | 47 | 0.70 |
|
| |||||||||
| Stage Group | I, II & III | 53% | 47% | 197 | – | – | |||
| (AJCC 6th Ed.) | IVA & IVB | 29% | 71% | 374 | 21% | 79% | 161 | ||
| IVC | 29% | 71% | 49 | 7% | 93% | 12 | |||
| Unknown | 30% | 70% | 167 | 0.0012* | 16% | 84% | 9 | 0.18 | |
|
| |||||||||
| T Class | T1 | 64% | 36% | 139 | – | – | – | ||
| (2 missing) | T2 | 39% | 61% | 192 | – | – | – | ||
| T3 | 16% | 84% | 83 | – | – | – | |||
| T4 | 21% | 79% | 182 | 21% | 79% | 182 | |||
| Unknown | 25% | 75% | 189 | <0.0001* | – | – | – | <0.0001* | |
|
| |||||||||
| N Class | N0 | 51% | 49% | 167 | 45% | 55% | 29 | ||
| N1 | 34% | 66% | 171 | 4% | 96% | 32 | |||
| N2 | 30% | 70% | 338 | 22% | 78% | 90 | |||
| N3 | 23% | 77% | 32 | 9% | 91% | 16 | |||
| Unknown | 43% | 57% | 79 | 0.06 | 26% | 74% | 15 | 0.0045* | |
|
| |||||||||
| M Class | M0 | 38% | 62% | 686 | 21% | 79% | 161 | ||
| M1 | 29% | 71% | 49 | 7% | 93% | 12 | |||
| Unknown | 25% | 75% | 52 | 0.17 | 16% | 84% | 9 | 0.18 | |
|
| |||||||||
| Residency | Yes | 36% | 64% | 494 | 24% | 76% | 123 | ||
| Program | No/ Unknown | 38% | 62% | 293 | 0.75 | 13% | 87% | 59 | 0.12 |
|
| |||||||||
| Hospital Beds | 1–299/Unknown | 37% | 63% | 318 | 12% | 88% | 69 | ||
| ≥ 300 | 35% | 65% | 469 | 0.76 | 26% | 74% | 113 | 0.0055* | |
RTC= radiotherapy with or without chemotherapy
†
Excluded patients who either received chemotherapy or no cancer directed therapy
‖
Weighted Rao-Scott Chi-Square P-value
*
Significant at α = 0.05